Daniel Schiwek demonstrates the value of Gyrolab in HCP analysis and bioprocess
Daniel Schiwek, Project Evaluation Manager at Global Biological Operations, Lonza AG,Visp, Switzerland, presented ‘Biopharmaceutical manufacturing in microbial systems – Gyrolab™ as an analytical platform supporting process development’ at the Gyrolab Seminar, 2011, held in Siena, Italy.
Gyrolab workstation was compared with ELISA for HCP analysis and delivered:
- Faster assay development times
- Reduced consumption of reagents and samples
- Reduced matrix effects (lower sample dilution)
- Increased dynamic range
You can find out more about this work in the poster by Peiris and Schiwek : Download
Note: To view the presentation on full screen, press ‘full screen’ before starting the presentation. Use ‘Outline’ to view selected sections of the presentation.